Bath & Body Works (NYSE:BBWI) Given New $52.00 Price Target at Deutsche Bank Aktiengesellschaft

Bath & Body Works (NYSE:BBWI) had its target price raised by Deutsche Bank Aktiengesellschaft from $51.00 to $52.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target indicates a potential upside of 44.77% from the stock’s current price.

BBWI has been the subject of a number of other reports. BMO Capital Markets reissued an “outperform” rating and issued a $50.00 target price (down from $52.00) on shares of Bath & Body Works in a report on Thursday, August 29th. Robert W. Baird reduced their target price on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating on the stock in a report on Thursday, August 29th. Piper Sandler increased their price target on shares of Bath & Body Works from $35.00 to $36.00 and gave the company a “neutral” rating in a report on Tuesday. The Goldman Sachs Group reduced their price objective on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating on the stock in a research note on Thursday, August 29th. Finally, Barclays upped their price objective on Bath & Body Works from $28.00 to $34.00 and gave the company an “underweight” rating in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $41.88.

Bath & Body Works Price Performance

BBWI opened at $35.92 on Tuesday. The firm has a market cap of $7.87 billion, a P/E ratio of 8.83, a PEG ratio of 1.14 and a beta of 1.79. The company has a 50 day simple moving average of $30.81 and a two-hundred day simple moving average of $35.65. Bath & Body Works has a 1-year low of $26.20 and a 1-year high of $52.99.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.54 billion. Equities analysts anticipate that Bath & Body Works will post 3.18 earnings per share for the current year.

Insider Buying and Selling at Bath & Body Works

In related news, CEO Gina Boswell purchased 6,000 shares of Bath & Body Works stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the transaction, the chief executive officer now directly owns 242,987 shares in the company, valued at approximately $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.27% of the company’s stock.

Hedge Funds Weigh In On Bath & Body Works

A number of hedge funds have recently made changes to their positions in the company. CWM LLC increased its position in shares of Bath & Body Works by 6.6% during the second quarter. CWM LLC now owns 5,072 shares of the company’s stock worth $198,000 after purchasing an additional 314 shares in the last quarter. Northwest Bank & Trust Co lifted its stake in shares of Bath & Body Works by 2.5% in the first quarter. Northwest Bank & Trust Co now owns 13,094 shares of the company’s stock worth $655,000 after buying an additional 315 shares in the last quarter. DekaBank Deutsche Girozentrale boosted its position in Bath & Body Works by 1.0% during the first quarter. DekaBank Deutsche Girozentrale now owns 31,797 shares of the company’s stock worth $1,560,000 after acquiring an additional 322 shares during the last quarter. TD Private Client Wealth LLC grew its stake in Bath & Body Works by 24.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after acquiring an additional 331 shares in the last quarter. Finally, Citizens & Northern Corp raised its holdings in Bath & Body Works by 1.7% in the 2nd quarter. Citizens & Northern Corp now owns 29,465 shares of the company’s stock valued at $1,151,000 after acquiring an additional 487 shares during the last quarter. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.